Title : Treatment of mycosis fungoides with oral bexarotene combined with PUVA.

Pub. Date : 2002 Sep

PMID : 12847736






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bexarotene has recently been approved in the United States and Europe as a single orally administered retinoid for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who are refractory to at least one prior systemic therapy. Bexarotene TSPY like 2 Homo sapiens